Difference between revisions of "Hoffmann M, et al, Cell (2020), cited as Ref 13 in DOI: 10.1007/s11886-020-01293-2 (Q11007)"
Jump to navigation
Jump to search
(Created claim: title (P93): SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. In vitro study demonstrating critical roles of ACE2 MPRSS2 in SARS-CoV-2 cell entry., #quickstat...) |
(Created claim: Published In Name String (P102): Cell, #quickstatements; #temporary_batch_1592836225919) |
||||||||||||||
| (8 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2020
| ||||||||||||||
| Property / Publication Date: 2020 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / First Author string | |||||||||||||||
| + | Hoffmann M | ||||||||||||||
| Property / First Author string: Hoffmann M / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Second Author string | |||||||||||||||
| + | Kleine-Weber H | ||||||||||||||
| Property / Second Author string: Kleine-Weber H / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Third Author string | |||||||||||||||
| + | Schroeder S | ||||||||||||||
| Property / Third Author string: Schroeder S / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Fourth Author string | |||||||||||||||
| + | Kruger N | ||||||||||||||
| Property / Fourth Author string: Kruger N / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Fifth Author string | |||||||||||||||
| + | Herrler T | ||||||||||||||
| Property / Fifth Author string: Herrler T / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Sixth Author string | |||||||||||||||
| + | Erichsen S | ||||||||||||||
| Property / Sixth Author string: Erichsen S / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Seventh Author string | |||||||||||||||
| + | el al | ||||||||||||||
| Property / Seventh Author string: el al / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Cell | ||||||||||||||
| Property / Published In Name String: Cell / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 14:30, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hoffmann M, et al, Cell (2020), cited as Ref 13 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. In vitro study demonstrating critical roles of ACE2 MPRSS2 in SARS-CoV-2 cell entry. (English)
0 references
2020
0 references
Hoffmann M
0 references
Kleine-Weber H
0 references
Schroeder S
0 references
Kruger N
0 references
Herrler T
0 references
Erichsen S
0 references
el al
0 references
Cell
0 references
